OSR Holdings, Inc. (OSRH)
Automate Your Wheel Strategy on OSRH
With Tiblio's Option Bot, you can configure your own wheel strategy including OSRH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OSRH
- Rev/Share 0.0
- Book/Share -2.7959
- PB -0.4864
- Debt/Equity -0.3952
- CurrentRatio 0.0678
- ROIC 2.1683
- MktCap 26216690.0
- FreeCF/Share -0.9432
- PFCF -11.9823
- PE -1.3086
- Debt/Assets 1.1129
- DivYield 0
- ROE -0.1721
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token
Published: May 22, 2025 by: PRNewsWire
Sentiment: Neutral
SEOUL, South Korea and ZUG, Switzerland , May 22, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a public company dedicated to advancing innovation in healthcare and wellness, announced today that it has entered into a Memorandum of Understanding (MOU) with BCM Europe AG, its major shareholder, and Taekwondo Cooperative (TKD Coop), a global Taekwondo community organization, to explore the joint development of a security token, provisionally named the "OSRH Token". The initiative aims to enhance access to crypto-based liquidity and provide a basis for OSRH to launch crypto treasury strategies.
Read More
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
Published: March 25, 2025 by: PRNewsWire
Sentiment: Neutral
BASEL, Switzerland, March 25, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr. Constance Höfer as its new Chief Scientific Officer (CSO). Dr. Höfer, a seasoned leader in drug development with over 20 years of experience in oncology and immunology, will oversee OSR Holdings' scientific strategy and innovation pipeline.
Read More
About OSR Holdings, Inc. (OSRH)
- IPO Date 2023-03-21
- Website https://www.osr-holdings.com
- Industry Biotechnology
- CEO Mr. Kuk Hyoun Hwang
- Employees 19